- Home
- MRUS vs TNET Comparison
MRUS vs TNET Comparison
Compare MRUS & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- TNET
- Stock Information
- Founded
- MRUS 2003
- TNET 1988
- Country
- MRUS Netherlands
- TNET United States
- Employees
- MRUS 260
- TNET N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- TNET Business Services
- Sector
- MRUS Health Care
- TNET Consumer Discretionary
- Exchange
- MRUS Nasdaq
- TNET Nasdaq
- Market Cap
- MRUS 4.1B
- TNET 3.9B
- IPO Year
- MRUS 2016
- TNET 2014
- Fundamental
- Price
- MRUS $53.11
- TNET $74.64
- Analyst Decision
- MRUS Strong Buy
- TNET Hold
- Analyst Count
- MRUS 12
- TNET 3
- Target Price
- MRUS $87.92
- TNET $90.00
- AVG Volume (30 Days)
- MRUS 2.0M
- TNET 242.8K
- Earning Date
- MRUS 07-31-2025
- TNET 07-25-2025
- Dividend Yield
- MRUS N/A
- TNET 1.46%
- EPS Growth
- MRUS N/A
- TNET N/A
- EPS
- MRUS N/A
- TNET 3.32
- Revenue
- MRUS $54,732,000.00
- TNET $4,999,000,000.00
- Revenue This Year
- MRUS $75.57
- TNET $1.76
- Revenue Next Year
- MRUS $31.84
- TNET $4.25
- P/E Ratio
- MRUS N/A
- TNET $22.60
- Revenue Growth
- MRUS 42.77
- TNET 1.19
- 52 Week Low
- MRUS $33.19
- TNET $65.43
- 52 Week High
- MRUS $62.98
- TNET $116.26
- Technical
- Relative Strength Index (RSI)
- MRUS 53.18
- TNET 32.50
- Support Level
- MRUS $52.41
- TNET $75.66
- Resistance Level
- MRUS $54.59
- TNET $83.79
- Average True Range (ATR)
- MRUS 2.15
- TNET 1.88
- MACD
- MRUS -0.77
- TNET -0.93
- Stochastic Oscillator
- MRUS 7.62
- TNET 18.16
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About TNET TriNet Group Inc.
TriNet offers outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.